Alliancebernstein L.P. Novo Cure LTD Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Novo Cure LTD stock. As of the latest transaction made, Alliancebernstein L.P. holds 132,330 shares of NVCR stock, worth $3.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,330

Previous 132,330 -0.0%

Holding current value

$3.84 Million

Previous $2.27 Million 8.74%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $1.15 Million - $2.34 Million	97,400 Added 278.84%	132,330 $2.27 Million
Q1 2024 May 14, 2024	SELL	$12.42 - $17.29 $39,768 - $55,362	-3,202 Reduced 8.4%	34,930 $545,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $43,395 - $61,526	3,899 Added 11.39%	38,132 $569,000
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $11,111 - $29,136	-688 Reduced 1.97%	34,233 $552,000
Q2 2023 Aug 15, 2023	BUY	$40.29 - $82.51 $55,076 - $112,791	1,367 Added 4.07%	34,921 $1.45 Million
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $619,090 - $1.3 Million	-10,969 Reduced 24.64%	33,554 $2.02 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $22,712 - $30,306	355 Added 0.8%	44,523 $3.27 Million
Q3 2022 Nov 15, 2022	SELL	$67.99 - $89.57 $23,184 - $30,543	-341 Reduced 0.77%	44,168 $3.36 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $28,526 - $45,309	-504 Reduced 1.12%	44,509 $3.09 Million
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $53,653 - $75,391	-892 Reduced 1.94%	45,013 $3.73 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $1.03 Million - $1.68 Million	-13,762 Reduced 23.06%	45,905 $3.45 Million
Q3 2021 Nov 10, 2021	BUY	$116.17 - $194.55 $676,806 - $1.13 Million	5,826 Added 10.82%	59,667 $6.93 Million
Q2 2021 Jul 30, 2021	SELL	$130.4 - $225.58 $417,280 - $721,856	-3,200 Reduced 5.61%	53,841 $11.9 Million
Q1 2021 May 06, 2021	BUY	$124.11 - $190.17 $53,367 - $81,773	430 Added 0.76%	57,041 $7.54 Million
Q4 2020 Feb 08, 2021	BUY	$112.16 - $174.14 $443,032 - $687,853	3,950 Added 7.5%	56,611 $9.8 Million
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $1.11 Million - $2.14 Million	-19,200 Reduced 26.72%	52,661 $5.86 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $6.37 Million - $8.29 Million	-111,449 Reduced 60.8%	71,861 $4.26 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $142,625 - $239,375	2,500 Added 1.38%	183,310 $12.3 Million
Q4 2019 Feb 18, 2020	BUY	$68.3 - $93.8 $2.34 Million - $3.22 Million	34,290 Added 23.4%	180,810 $15.2 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $1.57 Million - $2.49 Million	25,420 Added 20.99%	146,520 $11 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $565,748 - $847,282	13,400 Added 12.44%	121,100 $7.66 Million
Q1 2019 May 14, 2019	BUY	$31.96 - $56.12 $38,352 - $67,344	1,200 Added 1.13%	107,700 $5.19 Million
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $14,360 - $26,315	-500 Reduced 0.47%	106,500 $3.57 Million
Q3 2018 Nov 08, 2018	BUY	$32.0 - $52.4 $19,200 - $31,440	600 Added 0.56%	107,000 $5.61 Million
Q2 2018 Aug 13, 2018	BUY	$19.85 - $32.0 $500,220 - $806,400	25,200 Added 31.03%	106,400 $3.33 Million
Q1 2018 May 14, 2018	BUY	$19.3 - $23.65 $82,990 - $101,695	4,300 Added 5.59%	81,200 $1.77 Million
Q3 2017 Nov 13, 2017	BUY	$18.05 - $21.75 $1.39 Million - $1.67 Million	76,900	76,900 $1.53 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.04B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Novo Cure LTD Transaction History